ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

475
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
bullishSK Telecom
09 Oct 2017 03:05

SK Group Restructuring - Local Institutions Are Already Making A Move

We are now seeing a very interesting move from Korea's local institutions on those SK Group restructuring stocks. Last week, to be specific from...

Logo
349 Views
Share
05 Oct 2017 22:59

Foreign Investors Vs. Local Institutions in Korean Stock Market - Who Is Right?

Last month, foreign investors went on a buying spree in the Korea's second largest stock market, KOSDAQ. In contrast, they went on a selling spree...

Logo
1k Views
Share
04 Oct 2017 00:25

Biosimilar Battlefield: U.S. Humira Pushed to 2023

We are updating our market model to reflect the patent litigation settlement between Amgen Inc (AMGN US) and Abbvie Inc (ABBV US) , the...

Share
bullishCelltrion Inc
28 Sep 2017 22:05

Celltrion's KOSPI Move - Seo Jung-Jin, Temasek & Price Predictions

The big day (KOSPI move decision day) is tomorrow (Sep 29) for Celltrion Inc (068270 KS). At this point, many are thinking that Celltrion's KOSPI...

Logo
257 Views
Share
25 Sep 2017 09:29

The Week That Was in NorthAsia@Smartkarma: Sep24

It has been another week in North Asia. North Korean missile/nuclear tests and threats? Check. Trump rhetoric on North Korea and football players?...

Logo
186 Views
Share
x